PeptiDream Inc. carries a market capitalization of 899.45M, placing it among publicly traded companies globally. Its enterprise value stands at 293.81B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 899.45M |
| Enterprise Value | 293.81B |
PeptiDream Inc. currently has 129.61M shares outstanding.
| Shares Outstanding | 129.61M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
PeptiDream Inc. trades at a trailing price-to-earnings ratio of 13.76. The price-to-sales ratio is 5.38, and the price-to-book ratio stands at 5.08.
| PE Ratio | 13.76 |
| PS Ratio | 5.38 |
| PB Ratio | 5.08 |
| P/TBV Ratio | 6.18 |
| P/FCF Ratio | 108.03 |
| P/OCF Ratio | 300.92 |
On an enterprise value basis, PeptiDream Inc. trades at an EV/EBITDA multiple of 9.07 and an EV/FCF ratio of 66.92. The EV/Sales ratio of 5.30 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 9.07 provides insight into valuation relative to core operating earnings.
| EV / Sales | 5.30 |
| EV / EBITDA | 9.07 |
| EV / EBIT | 9.07 |
| EV / FCF | 66.92 |
PeptiDream Inc. maintains a current ratio of 3.39, meaning it holds 3.4x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 35.61, indicating elevated leverage, while an interest coverage ratio of 14.31 demonstrates strong ability to service its debt obligations.
| Current Ratio | 3.39 |
| Quick Ratio | 1.40 |
| Debt / Equity | 35.61 |
| Debt / EBITDA | 0.65 |
| Interest Coverage | 14.31 |
PeptiDream Inc. posts a return on equity of 48.31 and a return on invested capital of 33.25.
| Return on Equity (ROE) | 48.31 |
| Return on Assets (ROA) | 28.25 |
| Return on Invested Capital (ROIC) | 33.25 |
| Return on Capital Employed (ROCE) | 35.82 |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | 4.49 |
Over the trailing twelve months, PeptiDream Inc. has paid 8.52B in income taxes, reflecting an effective tax rate of 28.19.
| Income Tax | 8.52B |
| Effective Tax Rate | 28.19 |
PeptiDream Inc.'s stock has declined approximately -36.93694% over the past 52 weeks. The 50-day moving average sits at 6.31, while the 200-day moving average is 8.39.
| Beta (5Y) | N/A |
| 52-Week Price Change | -36.93694% |
| 50-Day Moving Average | 6.31 |
| 200-Day Moving Average | 8.39 |
| Average Volume (20 Days) | N/A |
Over the trailing twelve months, PeptiDream Inc. generated 55.42B in revenue and converted that into 21.69B in net income, yielding earnings per share of 167.21. EBITDA reached 32.41B, while operating income came in at 32.41B.
| Revenue | 55.42B |
| Gross Profit | 43.22B |
| Operating Income | 32.41B |
| Pretax Income | 30.21B |
| Net Income | 21.69B |
| EBITDA | 32.41B |
| EBIT | 32.41B |
| Earnings Per Share (EPS) | 167.21 |
PeptiDream Inc. holds 25.48B in cash and equivalents against 20.93B in total debt, resulting in a net debt position of -4.55B. Total book value stands at 58.77B, with working capital of 43.53B providing operational flexibility.
| Cash & Cash Equivalents | 25.48B |
| Total Debt | 20.93B |
| Net Debt | -4.55B |
| Equity (Book Value) | 58.77B |
| Book Value Per Share | 453.44 |
| Working Capital | 43.53B |
PeptiDream Inc. produced 991.54M in operating cash flow over the past twelve months. After subtracting -1.77B in capital expenditures, free cash flow totaled -781.20M - equivalent to -6.03 per share.
| Operating Cash Flow | 991.54M |
| Capital Expenditures | -1.77B |
| Free Cash Flow | -781.20M |
| FCF Per Share | -6.03 |
PeptiDream Inc. operates with a gross margin of 77.98, reflecting its pricing power and cost economics. The operating margin of 58.48 and net profit margin of 39.14 provide insight into operational efficiency.
| Gross Margin | 77.98 |
| Operating Margin | 58.48 |
| Pretax Margin | 54.51 |
| Profit Margin | 39.14 |
| EBITDA Margin | 58.48 |
| Dividend Per Share | N/A |
| Dividend Yield | N/A |
| Payout Ratio | N/A |
| Shareholder Yield | -0.36 |
| FCF Yield | 0.93 |
PeptiDream Inc.'s most recent stock split took place on June 28, 2017 with a 1:2 split ratio.
| Last Split Date | 6/28/2017 |
| Split Ratio | 1:2 |
PeptiDream Inc. posts an Altman Z-Score of 8.19, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | 8.19 |